Bergman Alan B.
SEC insider (Form 3/4/5 filer). CIK 0001907908. Chief Financial Officer at 20/20 Biolabs, Inc. (AIDX). 1 reported Form 4/5 transaction since Sep 2024; latest on Apr 2, 2026. Located in GAITHERSBURG, MD.
Companies Bergman Alan B. has filed insider reports for
- 20/20 Biolabs, Inc. (AIDX): Officer, Chief Financial Officer
Bergman Alan B.
CIK: 0001907908
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AIDX
20/20 Biolabs, Inc.
Officer